Delivery Order SPE2DB20D3505-SPE2DB21FT4Y9
- Not listed
- This federal contract award, valued at $1,381.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that provides Dexmethylphenidate ER 10 mg capsules in 100-count packages. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $2,042.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,557,785,231 units of Dexmethylphenidate ER 25 mg capsules. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024. The $1,912.02 firm-fixed-price delivery order is for the supply of 4,566,625,085 units of Dexmethylphenidate ER 30 mg capsules, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $2,522.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract involves the delivery of 4,562,953,314 units of Dexmethylphenidate ER 20 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order, with a performance period ending on December 1, 2023. It is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,192.88 firm fixed-price delivery order is for the supply of 4,566,552,109 units of Dexmethylphenidate ER 10 mg capsules. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,556,004,424 units of Dexmethylphenidate ER 10 mg Capsules. The firm-fixed-price Delivery Order, valued at $1,008.40, has a completion date of January 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The federal contract award summarized is for the delivery of 4,565,943,853 units of Dexmethylphenidate ER 20 mg capsules. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for a firm fixed price of $2,338.84. The contract is a delivery order with an ultimate completion date of September 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,804.90 delivery order covers the supply of 4,566,336,977 units of Dexmethylphenidate ER 10 mg capsules. The contract has a firm fixed price and a completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- This federal contract award, valued at $1,094.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dexmethylphenidate ER 20 mg capsules and has an ultimate completion date of January 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,514,754 units of the medication Dexmethylphenidate ER 20 mg capsules. The $5,785.27 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 22, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds significant Indefinite Delivery...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB21FT4Y9Delivery Order
This federal contract award, valued at $3,898.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,552,082,417 units of Dexmethylphenidate ER 25 mg capsules. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. In addition to the DLA contract, Cencora, Inc. also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to efficiently deliver essential pharmaceutical and medical commodities to multiple government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 12/29/20 |